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Hepatocyte apoptosisGGPPS catalyses the expression of GGPP, a key protein in the mevalonate metabolic pathway.
HMG-CoA reductase inhibitor statins can induce liver injury by inhibiting GGPP. However, the
function of GGPPS in liver injury has not yet been revealed. In this study, we found that GGPPS
increased in liver injury and that GGPPS deletion augmented liver injury and ﬁbrosis. GGPPS
inhibition induced hepatocyte apoptosis, inﬂammation and TGF-b1 secretion, which activated
hepatic stellate cells. Our ﬁndings imply that GGPPS deletion induces hepatocyte apoptosis, which
makes the liver vulnerable to hepatotoxicity.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. IntroductionLiver ﬁbrosis is characterised by the excessive accumulation of
extracellular matrix (ECM) proteins, which occurs in most types of
chronic liver diseases [1]. Toxicity and damage, including that
caused by chronic hepatitis C virus (HCV) infection, alcohol, non-
alcoholic steatohepatitis (NASH) and drugs, injure the liver and
promote the generation and release of growth factors (platelet-
derived growth factor (PDGF), transforming growth factor-beta 1
(TGF-b1), etc.) and cytokines that activate HSCs, the main
ECM-producing cells in the injured liver. After liver injury, the
activated form of HSCs play a vital function in the production
and degradation of ECM. The imbalance between ECM production
and degradation ultimately leads to liver ﬁbrosis.
Geranylgeranyl pyrophosphate (GGPP) is a key protein in the
mevalonate metabolic pathway and functions in the protein preny-
lation of small GTPases, which is necessary for their activation [2].
GGPP has been reported to have a vital function in the restoration
of statin-induced liver injury, which is an unavoidable type of
liver injury [3]. Many articles have reported severe hepatotoxicity
attributed to statins due to over-dose or idiosyncrasy [4]. A higher
dose of statin (P1 deﬁned daily dose) and the use of rosuvastatin
before the liver injury event are reported to be associated with liver
injury [5]. While inhibiting 3-hydroxy-3-methylglutarylcoenzyme
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induce cell death [3,6]. However, the inhibitory effect can be
reversed via the supplementation of mevalonate or GGPP [3].
GGPP is biosynthesized from acetyl-CoA through the meval-
onate metabolic pathway catalysed by geranylgeranyl diphosphate
synthase (GGPPS) [7,8]. The role of the catalytic enzyme GGPPS has
been revealed in many diseases. Shen et al. found that GGPPS func-
tions in the signalling pathway controlling cigarette smoke-in-
duced pulmonary inﬂammation [9]. Wang et al. reported that the
deletion of GGPPS in mouse Sertoli cells caused infertility [10].
The research by Xu et al. suggested that the cardiac-speciﬁc knock-
out of GGPPS resulted in hypertrophic cardiomyocyte growth [11].
Our previous study revealed that hepatocellular carcinoma (HCC)
patients with cirrhosis had relatively higher expression of GGPPS
[12]. Based on the understanding that GGPP has a prominent role
in the restoration of statin-induced liver injury, we speculate that
the catalytic enzyme GGPPS might also play a role in liver injury.
To date, the function of GGPPS in liver injury has not yet been
reported. In this study, we aim to investigate the role of GGPPS in
liver injury and to reveal the possible mechanism for its partic-
ipation in this common disease.
2. Materials and methods
2.1. Reagents
Carbon tetrachloride (CCl4), olive oil and polyriboinosinic-poly-
ribocytidylic (pIpC) dsRNA were purchased from Sigma Chemicals
Co. (USA). Primary antibodies against caspase-3, cleaved caspase-3,
caspase-9, cleaved caspse-9, poly ADP-ribose polymerase (PARP),
cleaved PARP, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), Mcl-2, Bcl-2, p-JNK, JNK, p-ERK, ERK, p-p65 and p65 were
purchased from Cell Signalling Technology (Beverly, MA). The pri-
mary antibody against GGPPS was obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, USA). TGF-b1 neutralization anti-
body (ab647) was purchased from Abcam (Abcam, Cambridge, UK).
2.2. Cell culture
The human liver cell line LO2 and the hepatic stellate cells (HSC)
cell line LX2 were obtained from the Cell Bank of Shanghai Institute
of Biological Sciences, Chinese Academy of Sciences. LO2 cells were
supported in RPMI-1640 medium (Gibco, Gaithersburg, MD) con-
taining 10% foetal bovine serum (FBS) (Gibco, Gaithersburg, MD).
HSC-LX2 cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco, Gaithersburg, MD) supplemented with
10% FBS. For co-culture experiments, LO2 cells were cultured in
DMEM containing 10% FBS. All of the cells were maintained at
37 C in an incubator supplemented with 5% CO2 under humidiﬁed
conditions.
2.3. Patients and samples
Liver specimens from6 patientswith liver cirrhosis and 6 patients
with hemangioma from the Department of Hepatobiliary Surgery of
Drum Tower Hospital were included in the study. This study was
approvedby the Scientiﬁc Research Ethics Committee of the afﬁliated
Drum Tower Hospital, Medical School of Nanjing University, and
informed consents were obtained from all participants.
2.4. Mice and CCl4 administration methods
Eight-week-old female C57BL/6 mice were used in acute liver
injury experiments. Liver-speciﬁc GGPPS knockout mice (GGPPS/)
were generated as described [13]. Brieﬂy, two LoxP sites were
inserted into the GGPPS gene, ﬂanking exons 3 and 4. Liver-speciﬁcGGPPS knock-out mice were generated by breeding GGPPS-ﬂoxed
micewithMx1-Cre transgenicmice, which express Cre recombinase.
Mx1-Cre GGPPSﬂox/ﬂoxmicewere termedGGPPS/, and GGPPSﬂox/ﬂox
mice obtained from the same breeding were termed as wild type. To
induce the deletion of GGPPS, GGPPS/ and control mice were
injected intraperitoneally (i.p.) with pIpC dsRNA (20 lg/g body
weight) three times at a 2-day interval. All animal procedures were
carried out in accordance with the Animal Care and Use Committee
of the Model Animal Research Centre of Nanjing University,
Nanjing, China.
For CCl4 administration, CCl4 was mixed with olive oil at the
volume ratio of 1:3. In the acute liver injury model, every mouse
was given a single i.p. injection of CCl4 (1 ll/g body weight) and
sacriﬁced after 0 h, 24 h, 48 h and 72 h. In the liver ﬁbrosis model,
every mouse was given two i.p. injections of CCl4 (1 ll/g body
weight) every week on Tuesday and Friday for 7 consecutive weeks
and sacriﬁced 1 week after the last injection. Olive oil (1 ll/g body
weight) was given to control mice. Each group contained 8 mice.
2.5. qRT-PCR
The relative mRNA level changes were determined by quantita-
tive real-time PCR. Brieﬂy, total RNA was extracted using TRIzol
reagent (TaKaRa, Japan) and the reverse transcribed to cDNA using
Primescript RT master mix (TaKaRa, Japan). The cDNA was sub-
jected to real-time PCR using a SYBR Green PCR Kit (TaKaRa,
Japan) and an ABI PRISM 7300 Sequence Detector. The internal
control was the 18S rRNA gene. The relative expression level was
calculated using the 2DDCt method. The primer sequences are
listed in Table 1.
2.6. Western blotting
Protein levels were determined by Western blotting following
published protocols [14]. Protein levels were detected by incubat-
ing immunoblots with primary antibody followed by incubation
with HRP-conjugated secondary antibody. The signal was devel-
oped with ECL (Millipore, Switzerland) and visualised using a
Tanon 5200 imaging system (Tanon, China).
2.7. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labelling (TUNEL) assay
Cell apoptosis in mouse liver was determined by a commercial
apoptosis detection kit (DeadEnd™ Fluorometric TUNEL System,
Promega) following the manufacturer’s instructions. The nuclear
was visualised by DAPI staining.
2.8. short hairpin RNA (shRNA) transfection
GGPPS-targeting oligonucleotide sequences were synthesized
and inserted into a GV115 lentiviral expression vector
(GeneChem, Shanghai, China). GGPPS targeting sequence: shRNA
1: TGAGCTAGTAGCCTTAGTA; shRNA 2: TTGAAGCTAAAGCCTATAA.
GGPPS shRNA 1 and 2 were transfected into LO2 cells using
Lipofectamine 2000 (Life Technologies, Carlsbad, CA) following the
manufacturer’s instructions. Vectors containing scramble sequences
were used as a negative control.
2.9. Flow cytometry
Cells were harvested and collected by centrifugation. Cells were
washed with PBS and resuspended in 500 ll binding buffer, after
which 5 ll of Annexin V-FITC and 5 ll of PI (Beyotime, Nantong,
China) were then added. The cells were incubated in the dark for
10 min and then subjected to ﬂow cytometric analysis.
Table 1
Primer sequences.
Gene
symbol
Forward primer
(50–30)
Reverse primer
(50–30)
mGGPPS TTCACCAACACCTGTAACTC TTATTGACAAGCCCAGAGC
hGGPPS TGGAGAAGACTCAAGAAACAG TCAGCCAATGATTAAATGCC
mCOL1A1 GCTCCTCTTAGGGGCCACT CCACGTCTCACCATTGGGG
hCOL1A1 GAGGGCCAAGACGAAGACATC CAGATCACGTCATCGCACAAC
ma-SMA GTCCCAGACATCAGGGAGTAA TCGGATACTTCAGCGTCAGGA
ha-SMA TCTGGAGGCACAACTGGCATCGT TACATATGTTGTCCCCCTGATAG
mCTGF GGGCCTCTTCTGCGATTTC ATCCAGGCAAGTGCATTGGTA
mFibronectin ATGTGGACCCCTCCTGATAGT GCCCAGTGATTTCAGCAAAGG
mIL-1a TGAAGAAGAGACGGCTGAG AGTGTTTGTCCACATCCTG
mIL-1b GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT
mIL-6 AGCCAGAGTCCTTCAGAGA GGATGGTCTTGGTCCTTAG
mTNF CCCTCACACTCAGATCATCTTCT GCTACGACGTGGGCTACAG
mFASL TCCGTGAGTTCACCAACCAAA GGGGGTTCCCTGTTAAATGGG
mCCL2 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT
mCCL3 CCTGCTGCTTCTCCTACA TCCAAGACTCTCAGGCATT
mCXCL2 CCCTGGTTCAGAAAATCATC TCCAAGACTCTCAGGCATT
mCXCL3 CACTCTCAAGGATGGTCAAG AGACACCGTTGGGATGGAT
mCXCL5 GAAGGAGGTCTGTCTGGAT TCATCAAAGCAGGGAGTTC
hIL-1b ACGCTCCGGGACTCACAGCA CCCTCCCAGGAAGACGGGCA
18S GTCTGTGATGCCCTTAGATG AGCTTATGACCCGCACTTAC
W.-B. Chen et al. / FEBS Letters 589 (2015) 1119–1126 11212.10. Histological examinations and immunohistochemistry (IHC)
All of the animals were sacriﬁced at the indicated time, and
the liver was collected for histological examination. The liver
was ﬁxed in 4% paraformaldehyde and embedded in parafﬁn.
The slices (5-lm thickness) were stained with haematoxylin
and eosin (H&E). The necrotic area in the liver was calculated
by Image-Pro Plus 6.0. Sirius red staining was used to measure
the hepatic collagen content in liver ﬁbrosis. In brief, deparaf-
ﬁnised liver sections were incubated with Sirius red for 2 h. The
red staining area was calculated by Image-Pro Plus 6.0. IHC was
performed following published protocols [15]. Primary antibodies
used were as follows: a-smooth muscle actin (SMA, 1:200,
Sigma–Aldrich, St. Louis), type I collagen (COL1A1) (1:100, Santa
Cruz, USA) and proliferating cell nuclear antigen (PCNA) (1:100,
Abcam). The pathological changes were assessed and pho-
tographed under an Olympus BX51 microscope. The positive
staining area was calculated by Image-Pro Plus 6.0.2.11. Cell viability assay
Cells were plated on 96-well plates at a density of 5  103 cells
per well and allowed to attach overnight. The cells were trans-
fected with GGPPS shRNA with/without necrostatin-1 for the indi-
cated period of time. Thereafter, CCK-8 (Dojindo Laboratories,
Japan) was added to each well and incubated for 2 h. Absorbance
values at 490 nm were recorded using a microplate reader.2.12. ALT and AST detection
Serum ALT and AST levels were detected using ALT and AST
detection kits (Nanjing Jiancheng Bioengineering Institute, China)
following the manufacturer’s instructions.Fig. 1. GGPPS is increased in liver injury. (A) Real-time PCR analysis of COL1A1 in
the patients’ liver cirrhotic tissues (n = 6). (B) Real-time PCR analysis of GGPPS in the
patients’ liver cirrhotic tissues (n = 6). (C) Real-time PCR analysis of COL1A1 in acute
liver injury in C57BL/6 mice (n = 8). (D) Real-time PCR analysis of GGPPS in acute
liver injury in C57BL/6 mice (n = 8). (N: normal, C: cirrhosis) (⁄P < 0.05, ⁄⁄P < 0.01).2.13. Mouse hepatocyte isolation
Mouse hepatocytes were isolated by collagenase perfusion
through the portal vein after which the liver was removed from
the surrounding capsule. The isolated hepatocytes were washed
with DMEM containing 10% FBS for 3 times. Then the cells were
seeded in 6-well plates for further experiments.2.14. Enzyme linked immunosorbent assay (ELISA)
TGF-b1 concentrations in transfected LO2 cell supernatants
were detected using a commercial TGF-b1 ELISA kit (Boster,
China) following the manufacturer’s instructions.
2.15. Statistical analysis
All of the data were expressed as the mean ± S.D. from three
individual experiments, and they were analysed using Student’s
t test and two-way ANOVA with Bonferroni correction.
P values < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. GGPPS expression increases in liver injury
To elucidate the function of GGPPS in liver injury, we ﬁrst
detected the GGPPS expression in liver cirrhosis by qRT-PCR.
Normal resected liver specimens from patients with liver heman-
gioma were used as the control. We found that COL1A1 mRNA
expression increased in cirrhotic tissues, which conﬁrmed the liver
cirrhosis background (Fig. 1A). The relative GGPPS expression level
also increased in cirrhotic tissues (Fig. 1B). Because acute liver
injury is believed to be the initial step towards liver ﬁbrosis, we
further detected the GGPPS level in an acute liver injury model in
mice. After 24 h of CCl4 injection, elevated COL1A1 mRNA expres-
sion was detected (Fig. 1C). Increased GGPPS levels were also found
in acute liver injury, which slightly decreased after 72 h. The above
observations conﬁrmed that GGPPS expression increased in liver
injury. The increased GGPPS level might play a role in the process
of liver injury.
3.2. GGPPS deletion augments CCl4-induced liver injury in mice
To demonstrate the function of GGPPS in liver injury in vivo, we
used liver-speciﬁc GGPPS knockout mice for further experiments.
Fig. 2A and B showed an approximate 50% knockout efﬁciency.
Fig. 2. GGPPS deletion augments CCl4-induced liver injury in mice. (A) GGPPS
knockout efﬁciency in GGPPS/ mouse liver detected by qRT-PCR (n = 7). (B) GGPPS
knockout efﬁciency in GGPPS/ mouse liver detected by Western blotting. (C) H&E
staining of liver sections at 24 h and 48 h after CCl4 administration in GGPPS/ and
WT mice. Quantiﬁcation of necrosis in the liver. (Arrow: necrotic area) (⁄P < 0.05).
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To examine the effects of GGPPS on CCl4-induced acute liver
injury, serum enzymes of liver function were measured (Table 2).
In the control groups, the ALT and AST activities were
10.88 ± 4.22 and 27.94 ± 5.02 U/L, respectively. There was no
obvious elevation of enzyme activity in the olive oil-treated
GGPPS/ mice. After CCl4 injection, more intensive increases of
ALT and AST activities were observed in GGPPS/ mice. After
24 h, the ALT activity in GGPPS/ mice was 197.76 ± 23.60 U/L
compared to 172.54 ± 7.60 U/L in WT mice (P < 0.05). The AST
activity in GGPPS/ mice after 48 h was 45.14 ± 11.49 U/L com-
pared to 28.78 ± 7.34 U/L in WT mice (P < 0.05). There was a recov-
ery trend after 48 h of CCl4 injection, as shown by the decreased
ALT and AST activities. However, GGPPS/ mice seemed to suffer
from a delayed recovery because the ALT activities in GGPPS/
mice after 72 h were still higher than that of the control.
The histological changes of the liver after CCl4 injection were
also analysed (Fig. 2C). Large areas of necrosis were found around
the vascular tissue in WT mice after 24 h. The necrosis was more
severe in GGPPS/ mice because the damage was disseminated
throughout the whole liver. In control mice, the histological dam-
age had recovered at 48 h; however, GGPPS/ mice still had larger
area of necrosis at this time.
These results demonstrated that GGPPS deletion made the liver
vulnerable to CCl4 toxicity.
3.3. GGPPS deletion augments CCl4-induced liver ﬁbrosis in mice
IHC stains were performed to evaluate the impact of GGPPS
deletion on proteins relevant to liver ﬁbrosis and proliferation,Table 2
ALT and AST activities in GGPPS/ and WT mice with acute liver injury.
Olive oil CCl4 24 h
WT GGPPS/ WT GGPPS/
ALT (U/L) 10.88 ± 4.22 17.23 ± 2.60 172.54 ± 7.60 197.76 ± 23.60
AST (U/L) 27.94 ± 5.02 26.91 ± 6.39 120.13 ± 6.72 126.47 ± 6.61
* P < 0.05.including a-SMA and PCNA. As shown in Fig. 3A, no apparent
expression of a-SMA was detected after 24 h in both WT and
GGPPS/mice. However, after 48 h, CCl4 signiﬁcantly up-regulated
the level of a-SMA in WTmice. A more intensive staining of a-SMA
was observed in GGPPS/ mice at 48 h. The expression pattern of
PCNA was in consistence with a-SMA (Fig. 3B). Stronger cell pro-
liferation was visualised in GGPPS/ mice at 48 h. The explanation
is likely that more severe hepatocyte damage required a stronger
level of repair. As expected, both the a-SMA and COL1A1 mRNA
level increased in GGPPS/ mice (Fig. 3C and D). The astonishing
ﬁnding was that both of these two genes increased even at the time
of 0 h. Inﬂammation in acute liver injury model was also detected
by qRT-PCR method. We found that the expression of IL-1a and
IL-1b in GGPPS/ mice was higher than WT mice even at 0 h
(Fig. 3E and F). This ﬁnding suggested that the GGPPS deletion
exerted cytotoxicity against hepatocytes and the administration
of CCl4 augmented the already-existing liver injury. This conclu-
sion offered a good explanation for the vulnerability to CCl4
toxicity in GGPPS/ mice.
To conﬁrm the hypothesis further, we adopted a chronic hepatic
ﬁbrosis model in mice. After inducing liver ﬁbrosis in WT and
GGPPS/ mice, IHC stains of a-SMA and COL1A1 were performed.
More intensive staining of a-SMA and COL1A1 was found in CCl4-
treated GGPPS/ mice than was found in WT mice (Fig. 3G and H).
As expected, olive oil-treated GGPPS/ also developed liver ﬁbro-
sis. The hepatic collagen content was also detected by Sirius red
staining (Fig. 3I). GGPPS knockout mice developed severe ﬁbrosis
in both oil and CCl4-treated group. The qRT-PCR results of
COL1A1 were in tune with the IHC results (Fig. 3J). Changes in
other liver ﬁbrosis markers, including connective tissue growth
factor (CTGF) and ﬁbronectin were more apparent in CCl4-treated
GGPPS/ mice (Fig. 3K and L).
Therefore, we speculated that GGPPS deletion impaired hep-
atocyte viability, which then activated HSCs, leading to the genera-
tion of ECM and liver ﬁbrosis.
3.4. Interfering with GGPPS expression in hepatocytes induced
apoptosis
To prove our hypothesis, we detected the apoptotic cells in
GGPPS/ and WT mouse liver by TUNEL assay which showed
increased apoptosis in GGPPS/ mice liver (Fig. 4A). We also
detected the apoptotic protein level in WT and GGPPS/ primary
hepatocytes, and found increased cleaved form of caspase-9
(Fig. 4B). To further conﬁrm our hypothesis, human hepatocyte line
LO2 cells were transfected with GGPPS shRNA. Fig. 4C and D show
the interference efﬁciency of the GGPPS shRNA. Cells transfected
with GGPPS shRNA 1 and 2 lost cell integrity and suffered from cell
death after 48 h of transfection (Fig. 4E). Flow cytometric analysis
revealed that apoptosis and necrosis were present in transfected
cells (Fig. 4F and G). However, the cytotoxicity was not reversed
by the tumour necrosis factor-alpha (TNF-a) inhibitor necro-
statin-1 (Fig. 4H). We further detected the protein level of apop-
totic proteins by Western blotting. In LO2 cells transfected with
GGPPS shRNA, the cleaved form of caspase-3, caspase-9 and PARP
increased compared to the control (Fig. 4I). The anti-apoptotic pro-
tein Mcl-1 and Bcl-2 decreased in the GGPPS shRNA groups (Fig. 4J).CCl4 48 h CCl4 72 h
WT GGPPS/ WT GGPPS/
* 161.87 ± 31.12 165.53 ± 16.68 38.04 ± 11.03 49.49 ± 6.93*
28.78 ± 7.34 45.14 ± 11.49* 30.18 ± 6.51 31.85 ± 5.80
Fig. 3. GGPPS deletion augments CCl4-induced liver ﬁbrosis in mice. (A) IHC staining of a-SMA in the liver in GGPPS/ and WT mice. Quantiﬁcation of a-SMA staining area in
the liver. (B) IHC staining of PCNA in the liver in GGPPS/ and WT mice. Quantiﬁcation of PCNA staining area in the liver. (C) Relative a-SMA mRNA changes of the liver
harvested at the indicated time in GGPPS/ and WT mice (n = 8). (D) Relative COL1A1 mRNA changes of the liver harvested at the indicated time in GGPPS/ and WT mice
(n = 8). (E) Relative IL-1amRNA changes of the liver harvested at the indicated time in GGPPS/ and WT mice (n = 8). (F) Relative IL-1bmRNA changes of the liver harvested
at the indicated time in GGPPS/ andWTmice (n = 8). (G) IHC staining of a-SMA in the liver in GGPPS/ andWTmice treated with olive oil and CCl4 for 7 consecutive weeks.
Quantiﬁcation of a-SMA staining area in the liver. (H) IHC staining of COL1A1 in the liver in GGPPS/ and WT mice treated with olive oil and CCl4 for 7 consecutive weeks.
Quantiﬁcation of COL1A1 staining area in the liver. (I) Sirius red staining of the liver in GGPPS/ and WT mice treated with olive oil and CCl4 for 7 consecutive weeks.
Quantiﬁcation of positive Sirius red staining area in the liver. (J) Relative COL1A1 mRNA changes of the liver in the liver ﬁbrosis model in GGPPS/ and WT mice (n = 8). (K)
Relative CTGF mRNA changes of the liver in the liver ﬁbrosis model in GGPPS/ and WT mice (n = 8). (L) Relative ﬁbronectin mRNA changes of the liver in the liver ﬁbrosis
model in GGPPS/ and WT mice (n = 8). (Arrow: positive a-SMA staining; Star: positive PCNA staining; Arrowhead: positive COL1A1 staining) (⁄P < 0.05, ⁄⁄P < 0.01).
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through apoptosis instead of necrosis.
3.5. Deletion of GGPPS in hepatocytes activates HSCs by promoting
inﬂammation and TGF-b1 secretion
Primary hepatocyte damage was supposed to activate HSCs
through the cellular interaction between hepatocytes and HSCs
via advanced inﬂammation and the secretion of cytokines and
growth factors. Therefore, we further investigated inﬂammation
and TGF-b1 levels in primary hepatocytes in GGPPS/ mouse liver
and GGPPS shRNA-transfected cells.
To our delight, the proinﬂammatory NF-jB and mitogen-
activated protein kinase (MAPK) pathways [16] were activated in
primary hepatocytes of GGPPS/ mouse liver and GGPPS shRNA-
transfected cells (Fig. 5A and C). The expression of cytokines
including IL-1a, IL-1b, IL-6, CCL3 and CXCL3 increased in primary
hepatocytes of GGPPS/ mouse liver (Fig. 5B). We also observed
that the expression of IL-1b was increased after interfering withGGPPS expression (Fig. 5D). Because TGF-b1 is one of the major
proﬁbrotic cytokines and growth factors [17], the concentrations
of TGF-b1 in the supernatants of GGPPS shRNA-transfected LO2
cells were determined by ELISA. The concentration of TGF-b1
increased almost 2 times after transfection (Fig. 5E). To prove our
hypothesis further, HSC-LX2 cells were cultured in GGPPS shRNA-
transfected LO2 supernatants for the indicated time. We detected
increased a-SMA both at the mRNA (Fig. 5F) and protein level
(Fig. 5H) after incubation for 24 h and 48 h. We also detected the
expression of TGF-b1 in HSC-LX2 cells after incubation with the
supernatants of GGPPS shRNA-transfected LO2 cells. We found
the expression of TGF-b1 in HSC-LX2 cells increased after incuba-
tion for 24 h and 48 h (Fig. 5G). So the increased TGF-b1 from
LO2 cells could promote the autocrine TGF-b1 from HSC-LX2, and
both sources of TGF-b1 activated HSC-LX2. To further prove that
the increased TGF-b1 was a key factor in inducing LX2 activation,
TGF-b1 neutralizing antibody (1 lg/ml) was incubated with
GGPPS shRNA-transfected LO2 cell medium supernatants at 37 C
for 2 h. Thereafter, the supernatants were incubated with LO2 cells
Fig. 4. Interfering with GGPPS expression in hepatocytes induced apoptosis. (A) Apoptotic cells in mouse liver were detected by TUNEL assay which showed increased
apoptosis in GGPPS/ mice. Quantiﬁcation of TUNEL positive cells. (B) Western blotting results of cleaved caspase-9 in mouse primary hepatocytes. (C) GGPPS interference
efﬁciency of GGPPS shRNA 1 and 2 as detected by Western blotting. (D) GGPPS interference efﬁciency of GGPPS shRNA 1 and 2 as detected by qRT-PCR. (E) Morphological
changes of LO2 cells transfected with GGPPS shRNA. (F) Flow cytometric analysis revealed apoptosis and necrosis in GGPPS shRNA-transfected LO2 cells. Cells were harvested
48 h after shRNA transfection and subjected to ﬂow cytometry. (G) Relative apoptotic cell counts in LO2 cells transfected with GGPPS shRNA. (H) LO2 cells were transfected
with GGPPS shRNA in the presence of the TNF-a inhibitor necrostatin-1 (10 lM) for 48 h. Necrostatin-1 could not reverse GGPPS shRNA-induced cell death. (I) Western
blotting results of apoptotic proteins: caspase-3, caspase-9 and PARP. Cells were harvested 48 h after shRNA transfection. (J) The expression of the anti-apoptotic proteins
Mcl-1 and Bcl-2 decreased 48 h after GGPPS shRNA transfection. (CF: cleaved form) (⁄P < 0.05).
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gated the increase of a-SMA in the protein level (Fig. 5I).
Those results proved that the deletion of GGPPS in hepatocytes
can activate HSCs by promoting inﬂammation and TGF-b1
secretion.
4. Discussion
Liver ﬁbrosis is deﬁned by the overgrowth and scarring of many
tissues and is attributed to excess deposition of ECM [17]. The for-
mation of liver ﬁbrosis consists of a primary liver injury and the
subsequent activation of HSCs. In this study, we evaluated the role
of GGPPS in the maintenance of hepatocyte integrity. We found
that GGPPS expression increased in liver cirrhosis and acute liver
injury. GGPPS deletion in mice liver augmented liver injury and
ﬁbrosis. The underlying mechanism was also investigated.
We found thatGGPPSdeletion activated the cleavage of apoptotic
proteins and decreased the protein level of antiapoptotic protein
Mcl-1 and Bcl-2. GGPPS deletion induced hepatocyte apoptosis.
GGPPS was essential for the post-translational geranylgeranylationof monomeric small GTPase signalling proteins [18]. The Ras super-
family is the most studied small GTPase and functions in many
important biological processes [7]. The modiﬁcations of Ras include
the covalent attachment of farnesyl pyrophosphate (FPP) or GGPP to
the cysteine residue of the CAAX motif by prenylation [2]. Protein
geranylgeranylation plays a critical role in the regulation of cell sur-
vival [19]. The depletion of GGPP was found to be involved in cas-
pase-dependent apoptosis induced by lipophilic statins [6]. Xia
et al. found that the inhibition of protein geranylgeranylation by
lovastatin induces apoptosis in acute myeloid leukaemia cells [20].
When incubating with statins, only GGPP depletionwas responsible
for the apoptotic response [20,21].
The mechanism by which GGPPS deletion induces hepatocyte
apoptosis may be the result of the down-regulation of the
antiapoptotic proteins Mcl-1 and Bcl-2. Van et al. revealed that
lovastatin induces apoptosis in myeloma and lymphoma cells by
inhibiting protein geranylgeranylation. Mcl-1 and Bcl-2 were
found to be subsequently down-regulated after the inhibition of
geranylgeranylation [22]. Kubota et al. found that simvastatin inhi-
bits the protein and mRNA expression of Bcl-2. While inhibiting
Fig. 5. Deletion of GGPPS in hepatocytes activates HSCs by promoting inﬂammation and TGF-b1 secretion. (A) Proinﬂammatory NF-jB and MAPK pathways were activated in
primary hepatocytes in GGPPS/ mice. (B) Inﬂammation was activated in primary hepatocytes in GGPPS/ mice. qRT-PCR results of cytokines in primary hepatocytes. (C)
Proinﬂammatory NF-jB and MAPK pathways were activated in GGPPS shRNA transfected cells. (D) IL-1b increased in GGPPS shRNA-transfected LO2 cells. (E) TGF-b1 increased
in GGPPS shRNA-transfected LO2 cell medium supernatants. (F) qRT-PCR results of a-SMA in LX2 cells co-cultured in GGPPS shRNA-transfected LO2 medium supernatants. (G)
qRT-PCR results of TGF-b1 in LX2 cells co-cultured in GGPPS shRNA-transfected LO2 medium supernatants. (H) Western blotting results of a-SMA in LX2 cells co-cultured in
GGPPS shRNA-transfected LO2 medium supernatants. (⁄P < 0.05). (I) Neutralization of TGF-b1 (1 lg/ml) abrogated the increase of a-SMA in LX2 cells co-cultured in GGPPS
shRNA-transfected LO2 medium supernatants.
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geranylgeranylation of Rho, which inﬂuences Bcl-2 expression.
The down-regulation of Bcl-2 induced the downstream caspase-
dependent cell death [6]. RhoA inactivation was implicated in the
aetiology of mitochondrial membrane depolarization and apopto-
sis in lipophilic statin-treated cells [3]. Because the inhibition of
geranylgeranylation of Rho proteins was found to be an important
cause of statin-induced apoptosis [23], we speculated that the
induced cell death after GGPPS deletion is likely attributable to
the decreased protein geranylgeranylation of RhoA, which further
impaired Bcl-2 and Mcl-1 expression. The down-regulation of
antiapoptotic proteins leads to mitochondrial depolarization and
the activation of caspase-dependent cell death.
The formation of liver ﬁbrosis requires the activation of HSCs,
the main source of myoﬁbroblasts in the liver [24,25].
Inﬂammation and TGF-b1 are the common causes of HSC activa-
tion [26]. The proinﬂammatory NF-jB and MAPK pathways were
reported to be activated in GGPPS-deﬁcient Sertoli cells and after
viral infection [16]. Proinﬂammatory cytokine IL-1b was also
up-regulated in GGPPS-deﬁcient Sertoli cells [10], while the
overexpression of TGF-b1 resulted in cardiac hypertrophy charac-
terised by ﬁbrosis [27]. Therefore, in our research, we evaluated
inﬂammation and the TGF-b1 level in hepatocytes transfected with
GGPPS shRNA. The increased NF-jB and MAPK pathway activation
and IL-1b expression in LO2 cells transfected with GGPPS shRNA
conﬁrmed our hypothesis. TGF-b1 concentrations also increased
in the supernatants of the transfected cells. The increasedinﬂammation and TGF-b1 level were able to activate HSCs, as we
observed that a-SMA in LX2 cells increased after incubating the
cells with the medium supernatants which could be abrogated
by TGF-b1 neutralizing antibody.
In summary, GGPPS deletion in the liver augmented liver injury,
and the subsequent liver ﬁbrosis induced by CCl4. This ﬁnding was
attributed to the fact that GGPPS deletion impaired hepatocyte via-
bility and made the liver vulnerable to toxicity. Moreover, we
report here for the ﬁrst time that GGPPS deletion induced apoptosis
in hepatocytes, leading to increased inﬂammation and cytokine
secretion, which further activated HSCs. GGPPS played a protective
role in maintaining hepatocyte integrity under the circumstances
of external and internal offences. Thus, these ﬁndings provide
strong evidence for many drug-induced liver injuries, including
statin-induced liver injury. The restoration of protein geranylger-
anylation might confer a beneﬁt on statin-induced liver injury.
Further investigations are still needed.
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